Physician-owned pathology practice continues growth trajectory
May 1, 2026 (AUSTIN) – Oculus Pathology today announced its acquisition of Histopath, an anatomic pathology practice serving the Coastal Bend of Texas.
The acquisition brings Histopath’s laboratory operations into the Oculus Pathology network, headquartered in Austin. In addition, the following Histopath pathologists will join Oculus Pathology’s more than 45 specialty and subspecialty pathologists.
- Michael E. Bailey, M.D.
- Thomas M. Turner, Jr., M.D.
- Katrina L. Salazar, M.D., Ph.D.
- Aaron M. Harvey, M.D.
“Our priority is providing more physician practices and hospitals with accurate and reliable diagnostic capabilities and the collaboration that defines great pathology partnerships,” said Matt Thompson, chief executive officer of Oculus Pathology. “With this acquisition, we enhance our subspecialty depth and infrastructure while maintaining the personalized service model our partners depend on.”
“Joining Oculus Pathology means Histopath clients will have access to one of the largest physician-owned labs and pathology practices for timely diagnostic results, specialty and subspecialty expertise, and peer-to-peer consultations,” said Michael Bailey, M.D.
Oculus Pathology continues to expand strategically through physician-aligned growth, focused on diagnostic rigor and accuracy, operational reliability, and deep commitment to patient-centered care. Last month, the lab added specialty physician practices, ambulatory surgery centers, and outpatient practices in the Las Vegas and Phoenix markets to its service area.
“Oculus Pathology’s number one priority is providing timely, accurate pathology results to support targeted and compassionate patient care,” said Edward Weir, M.D., president, Oculus Pathology board of directors and pathologist with Oculus Pathology since 2005. “In an era of increasingly commoditized healthcare, we proudly maintain our independent, physician-owned, physician-led practice that values collaboration, long-term partnership, and a commitment to advancing the field of pathology. This acquisition enables us to make our model available to more hospitals and practices.”
The acquisition is privately financed and involves no private equity investment.
–30–
ABOUT OCULUS PATHOLOGY
Oculus Pathology is physician-owned and has been at the forefront of anatomic and clinical pathology services for more than 75 years. CLIA-certified and accredited by the College of American Pathologists, Oculus Pathology is renowned for its commitment to precision, innovation, and partnership. Oculus Pathology delivers unparalleled pathology lab expertise to hospitals and healthcare systems, ambulatory surgery centers, clinics, and specialty physician practices in Texas, Nevada, Arizona, and the Bahamas and medical directorships for hospitals nationwide. Learn more at ThinkOculus.com.
